1997
DOI: 10.3109/02652049709006810
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan microcapsules as controlled release systems for insulin

Abstract: This study analyses the use of chitosan for the production of surface crosslinked microparticulate systems containing insulin. The microcapsules were prepared by an innovative technique based on interfacial crosslinkage of different amounts of chitosan solubilized in the inner phase of a water/oil emulsion by means of ascorbyl palmitate. The correlation between the main formulation parameters and the functional properties of the microcapsules were analysed. Insulin is incorporated with high efficiency. The pep… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
46
0
1

Year Published

2001
2001
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 121 publications
(47 citation statements)
references
References 17 publications
0
46
0
1
Order By: Relevance
“…The significant increase may be because of the increase in the viscosity of the droplets (due to the increase in concentration of polymer solution). This increase is high enough to result in difficult dispersion and subdivision of droplets reported (21). Increase in MPS due to increased viscosity of the polymer solution has also been reported (22,23).…”
Section: Particle Size Distributionmentioning
confidence: 79%
“…The significant increase may be because of the increase in the viscosity of the droplets (due to the increase in concentration of polymer solution). This increase is high enough to result in difficult dispersion and subdivision of droplets reported (21). Increase in MPS due to increased viscosity of the polymer solution has also been reported (22,23).…”
Section: Particle Size Distributionmentioning
confidence: 79%
“…So far there are no delivery systems for foods which are designed to enhance the efficiency and stability of bioactive agents [15].…”
Section: Introductionmentioning
confidence: 99%
“…Because chitosan shares some characteristics with glycosaminoglycans (GAG) and hyaluronic acid, it is used in various tissue engineering applications (Suh and Matthew 2000). In addition, the biodegradabe, biocompatible, non-antigenic, non-toxic and bifunctional properties of chitosan make this polymer a suitable material for biomedical applications such as wound dressings (Hirano et al 1990) and drug delivery (Aiedeh et al 1997). It is known that chitosan plays a role in cell attachment and proliferation (Zhu et al 2002).…”
Section: Introductionmentioning
confidence: 99%